Component information
No US or EU label exists for this exact combination, so information is shown for each component.
Use: EPIVIR is a nucleoside analogue indicated in combination with other antiretroviral agents for the treatment of human immunodeficiency virus type 1 (HIV‑1) infection. US FDA label
Use: Nevirapine tablets are indicated in combination with other antiretroviral agents for the treatment of human immunodeficiency virus (HIV-1) infection in adults and pediatric patients 15 days and older [see Clinical… US FDA label
- zidovudine no separate page
Note: Fixed-dose combinations may not allow the dose changes advised for each component; check the strength and use the single agents if a component needs adjusting.
Dosing: Altered kidney function
No kidney-specific text is available from the US label for this generic yet. Check the Philippine package insert in the products table.
Kidney dosing for each component (single-agent) is shown under Component information.
Kidney-specific guidance from renalcarematters.com: in preparation.
Dosage forms
Philippines
- Film-coated tablet: 300 mg/200 mg/150 mg
Registered products in the Philippines
1 product registered with the Food and Drug Administration (FDA) Philippines list Lamivudine + Nevirapine + Zidovudine as the generic name. Registration status changes; confirm a product's current status on the FDA portal before relying on it.
| Package insert | |||||||
|---|---|---|---|---|---|---|---|
NoneZidovudine + Nevirapine + Lamivudine | 300mg/200mg/150mg Film-Coated TabletBy 60's in a white Opaque Round 100 CC HDPE Containers with 38 mm Neck Finish Closed with 38 mm White Opaque Polypropylene Stock Ribbed Closure with Wad having Induction Sealing Liner (Box of 1's) | Rx | AUROBINDO PHARMA LIMITED - UNIT IIIIndia | FABERCO LIFE SCIENCES INC. | DR-XY46462 | Nov 23, 2028 |
Source: FDA Philippines product registration database. "Valid until" is the registration validity date listed by the FDA; a past date may mean a renewal is pending. Package insert links point to files published by the FDA.
Formulary and pricing (Philippines)
Formulary and coverage
| Philippine National Formulary | Listed as Lamivudine + Zidovudine + Nevirapine |
| PNF listing | Oral: 150 mg + 300 mg + 200 mg tablet |
| PhilHealth GAMOT | No |
Sources:
- PNF Essential Medicines List, 8th ed. (as of November 2, 2022), DOH; https://www.philhealth.gov.ph/partners/providers/pdf/PNF-EML_11022022.pdf, as of November 2, 2022
Check availability
Prices and stock vary by branch; renalcarematters.com does not sell medicines or receive payment from pharmacies.
References
- Food and Drug Administration Philippines. Verification portal (product registrations). https://verification.fda.gov.ph
- PNF Essential Medicines List, 8th ed. (as of November 2, 2022), DOH; https://www.philhealth.gov.ph/partners/providers/pdf/PNF-EML_11022022.pdf
This page shows official label and registry text only; no renalcarematters.com clinical summary has been approved for it yet.
Last updated: .